TrialAnnals of oncology : official journal of the European Society for Medical Oncology2014

Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck: results of the randomized phase I/II ADVANTAGE trial (phase II part).

J B Vermorken et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.